Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis.

The T2T concept was feasible and superior to unguided treatment. High rates of patients reached JADAS-MDA and JADA remission after 12 months. Approximately half of the patients achieved their therapy goals without a biologic.